Zen Technologies Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 11, 2025, 12:12 am

Competitors of Zen Technologies Ltd

All Competitor Stocks of Zen Technologies Ltd

Quarterly Result

Last Updated: August 1, 2025, 9:00 am

Below is a detailed analysis of the quarterly data for Zen Technologies Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 111.00 Cr.. The value appears to be declining and may need further review. It has decreased from 294.00 Cr. (Mar 2025) to 111.00 Cr., marking a decrease of 183.00 Cr..
• For Expenses, as of Jun 2025, the value is 73.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 199.00 Cr. (Mar 2025) to 73.00 Cr., marking a decrease of 126.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 38.00 Cr.. The value appears to be declining and may need further review. It has decreased from 94.00 Cr. (Mar 2025) to 38.00 Cr., marking a decrease of 56.00 Cr..
• For OPM %, as of Jun 2025, the value is 34.00%. The value appears strong and on an upward trend. It has increased from 32.00% (Mar 2025) to 34.00%, marking an increase of 2.00%.
• For Other Income, as of Jun 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 4.00 Cr..
• For Interest, as of Jun 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 3.00 Cr..
• For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 53.00 Cr.. The value appears to be declining and may need further review. It has decreased from 112.00 Cr. (Mar 2025) to 53.00 Cr., marking a decrease of 59.00 Cr..
• For Tax %, as of Jun 2025, the value is 31.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Mar 2025) to 31.00%, marking an increase of 7.00%.
• For Net Profit, as of Jun 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 85.00 Cr. (Mar 2025) to 37.00 Cr., marking a decrease of 48.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 4.11. The value appears to be declining and may need further review. It has decreased from 9.41 (Mar 2025) to 4.11, marking a decrease of 5.30.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:23 pm

Growth

Last Updated: September 5, 2025, 1:56 pm

Balance Sheet

Last Updated: August 11, 2025, 3:08 pm

Below is a detailed analysis of the balance sheet data for Zen Technologies Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2024) to 9.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,680.00 Cr.. The value appears strong and on an upward trend. It has increased from 445.00 Cr. (Mar 2024) to 1,680.00 Cr., marking an increase of 1,235.00 Cr..
• For Borrowings, as of Mar 2025, the value is 54.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1.00 Cr. (Mar 2024) to 54.00 Cr., marking an increase of 53.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 132.00 Cr.. The value appears to be improving (decreasing). It has decreased from 264.00 Cr. (Mar 2024) to 132.00 Cr., marking a decrease of 132.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,875.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 718.00 Cr. (Mar 2024) to 1,875.00 Cr., marking an increase of 1,157.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 105.00 Cr.. The value appears strong and on an upward trend. It has increased from 79.00 Cr. (Mar 2024) to 105.00 Cr., marking an increase of 26.00 Cr..
• For CWIP, as of Mar 2025, the value is 7.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Mar 2024) to 7.00 Cr., marking a decrease of 4.00 Cr..
• For Investments, as of Mar 2025, the value is 218.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Mar 2024) to 218.00 Cr., marking an increase of 192.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,545.00 Cr.. The value appears strong and on an upward trend. It has increased from 603.00 Cr. (Mar 2024) to 1,545.00 Cr., marking an increase of 942.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,875.00 Cr.. The value appears strong and on an upward trend. It has increased from 718.00 Cr. (Mar 2024) to 1,875.00 Cr., marking an increase of 1,157.00 Cr..

Notably, the Reserves (1,680.00 Cr.) exceed the Borrowings (54.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Zen Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 32.07. This value is within the healthy range. It has increased from 15.45 (Mar 24) to 32.07, marking an increase of 16.62.
• For Diluted EPS (Rs.), as of Mar 25, the value is 32.07. This value is within the healthy range. It has increased from 15.34 (Mar 24) to 32.07, marking an increase of 16.73.
• For Cash EPS (Rs.), as of Mar 25, the value is 34.86. This value is within the healthy range. It has increased from 16.56 (Mar 24) to 34.86, marking an increase of 18.30.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 188.36. It has increased from 55.48 (Mar 24) to 188.36, marking an increase of 132.88.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 188.36. It has increased from 55.48 (Mar 24) to 188.36, marking an increase of 132.88.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 107.83. It has increased from 52.34 (Mar 24) to 107.83, marking an increase of 55.49.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 47.84. This value is within the healthy range. It has increased from 23.29 (Mar 24) to 47.84, marking an increase of 24.55.
• For PBIT / Share (Rs.), as of Mar 25, the value is 46.13. This value is within the healthy range. It has increased from 22.13 (Mar 24) to 46.13, marking an increase of 24.00.
• For PBT / Share (Rs.), as of Mar 25, the value is 44.98. This value is within the healthy range. It has increased from 22.15 (Mar 24) to 44.98, marking an increase of 22.83.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 33.16. This value is within the healthy range. It has increased from 15.41 (Mar 24) to 33.16, marking an increase of 17.75.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 31.04. This value is within the healthy range. It has increased from 15.22 (Mar 24) to 31.04, marking an increase of 15.82.
• For PBDIT Margin (%), as of Mar 25, the value is 44.36. This value is within the healthy range. It has decreased from 44.49 (Mar 24) to 44.36, marking a decrease of 0.13.
• For PBIT Margin (%), as of Mar 25, the value is 42.77. This value exceeds the healthy maximum of 20. It has increased from 42.29 (Mar 24) to 42.77, marking an increase of 0.48.
• For PBT Margin (%), as of Mar 25, the value is 41.71. This value is within the healthy range. It has decreased from 42.32 (Mar 24) to 41.71, marking a decrease of 0.61.
• For Net Profit Margin (%), as of Mar 25, the value is 30.74. This value exceeds the healthy maximum of 10. It has increased from 29.44 (Mar 24) to 30.74, marking an increase of 1.30.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 28.78. This value exceeds the healthy maximum of 20. It has decreased from 29.07 (Mar 24) to 28.78, marking a decrease of 0.29.
• For Return on Networth / Equity (%), as of Mar 25, the value is 16.47. This value is within the healthy range. It has decreased from 28.50 (Mar 24) to 16.47, marking a decrease of 12.03.
• For Return on Capital Employeed (%), as of Mar 25, the value is 23.07. This value is within the healthy range. It has decreased from 38.70 (Mar 24) to 23.07, marking a decrease of 15.63.
• For Return On Assets (%), as of Mar 25, the value is 13.67. This value is within the healthy range. It has decreased from 17.03 (Mar 24) to 13.67, marking a decrease of 3.36.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.02, marking an increase of 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.03. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.03, marking an increase of 0.03.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.69. It has decreased from 0.71 (Mar 24) to 0.69, marking a decrease of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 6.57. This value exceeds the healthy maximum of 3. It has increased from 2.29 (Mar 24) to 6.57, marking an increase of 4.28.
• For Quick Ratio (X), as of Mar 25, the value is 6.09. This value exceeds the healthy maximum of 2. It has increased from 1.66 (Mar 24) to 6.09, marking an increase of 4.43.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.39. This value is below the healthy minimum of 4. It has increased from 1.58 (Mar 24) to 2.39, marking an increase of 0.81.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 1.30 (Mar 24) to 0.00, marking a decrease of 1.30.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 1.21 (Mar 24) to 0.00, marking a decrease of 1.21.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 98.70 (Mar 24) to 0.00, marking a decrease of 98.70.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 98.79 (Mar 24) to 0.00, marking a decrease of 98.79.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 41.63. This value is within the healthy range. It has decreased from 85.79 (Mar 24) to 41.63, marking a decrease of 44.16.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 29.85. This value is within the healthy range. It has decreased from 56.71 (Mar 24) to 29.85, marking a decrease of 26.86.
• For Enterprise Value (Cr.), as of Mar 25, the value is 12,462.13. It has increased from 7,886.73 (Mar 24) to 12,462.13, marking an increase of 4,575.40.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 12.80. This value exceeds the healthy maximum of 3. It has decreased from 17.93 (Mar 24) to 12.80, marking a decrease of 5.13.
• For EV / EBITDA (X), as of Mar 25, the value is 28.85. This value exceeds the healthy maximum of 15. It has decreased from 40.30 (Mar 24) to 28.85, marking a decrease of 11.45.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 13.70. This value exceeds the healthy maximum of 3. It has decreased from 18.25 (Mar 24) to 13.70, marking a decrease of 4.55.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 98.69 (Mar 24) to 0.00, marking a decrease of 98.69.
• For Price / BV (X), as of Mar 25, the value is 7.84. This value exceeds the healthy maximum of 3. It has decreased from 17.89 (Mar 24) to 7.84, marking a decrease of 10.05.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 13.70. This value exceeds the healthy maximum of 3. It has decreased from 18.25 (Mar 24) to 13.70, marking a decrease of 4.55.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness